QSV Biologics contract cGMP manufacturer moves ahead.
QSV Biologics, a North American based contract biopharmaceutical manufacturer, continues to expand its operations and capabilities. Since January 2005 QSV has validated an additional two new cGMP manufacturing suites and is looking to construct another cGMP suite within its current facility. The existing manufacturing facility has been in operation since 1996 and future plans for constructing additional manufacturing areas are already underway. To facilitate expansion of the manufacturing operations, QSV signed a long term lease in May 2005 for 3200 square feet of office space adjacent to the manufacturing plant. QSV is also moving forward to acquire an additional 1.7 acres of land adjacent to the facility for expansion in the range of 5,000 liter to 10,000 liter bioreactor scale.
Other news from the department manufacturing

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.